PMGC Holdings (ELAB) Assets Average (2023 - 2026)
PMGC Holdings' (ELAB) quarterly Assets Average came in at $31.3 million in Q2 2026, up 242.73% year-over-year from $9.1 million in Q2 2025, and up 60.91% quarter-over-quarter from $19.5 million in Q1 2026.
Analysis
PMGC Holdings (ELAB) Assets Average (2023 - 2026) Analysis & Trends
PMGC Holdings has disclosed Assets Average across 4 years of filings, most recently posting $31.3 million for Q2 2026.
- In Q2 2026, Assets Average rose 242.73% year-over-year to $31.3 million; the TTM figure through Jun 2026 stood at $31.3 million (up 242.73% YoY), while the FY2025 annual figure was $10.9 million, up 54.14% from the prior year.
- Assets Average came in at $31.3 million for Q2 2026 at PMGC Holdings, up from $19.5 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $794.1 million in Q4 2023 to a low of $4.7 million in Q2 2024.
- Average Assets Average over 4 years is $83.3 million, with a median of $10.1 million recorded in 2024.
- Year-over-year, Assets Average slumped 98.73% in 2024 and soared 242.73% in 2026.
- Over 4 years, Assets Average stood at $794.1 million in 2023, then tumbled by 98.73% to $10.1 million in 2024, then soared by 37.67% to $13.9 million in 2025, then jumped by 125.12% to $31.3 million in 2026.
- Per Business Quant data, the three most recent Assets Average figures were $31.3 million in Q2 2026, $19.5 million in Q1 2026, and $13.9 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 207.26 Bn | 193.27 Bn | 7.24 Bn | 94.07 Bn |
| 2 | Gilead Sciences | 179.66 Bn | 176.48 Bn | 6.22 Bn | 52.82 Bn |
| 3 | Vertex Pharmaceuticals | 131.52 Bn | 123.67 Bn | 2.84 Bn | 26.95 Bn |
| 4 | Regeneron Pharmaceuticals | 81.77 Bn | 73.78 Bn | 3.93 Bn | 41.30 Bn |
| 5 | Argenx Se | 61.15 Bn | 55.97 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.55 Bn | 48.41 Bn | 52.00 Mn | 11.22 Bn |
| 7 | Alnylam Pharmaceuticals | 33.38 Bn | 30.07 Bn | 992.69 Mn | 5.34 Bn |
| 8 | Biogen | 31.68 Bn | 30.40 Bn | 1.96 Bn | 30.78 Bn |
| 9 | Roivant Sciences | 29.12 Bn | 29.12 Bn | 1.16 Mn | 5.51 Bn |
| 10 | PMGC Holdings | 2.29 Mn | -16.50 Mn | 385,691.00 | 31.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31.30 Mn |
| Mar 31, 2026 | 19.45 Mn |
| Dec 31, 2025 | 13.90 Mn |
| Sep 30, 2025 | 12.16 Mn |
| Jun 30, 2025 | 9.13 Mn |
| Mar 31, 2025 | 8.94 Mn |
| Dec 31, 2024 | 10.10 Mn |
| Sep 30, 2024 | 8.14 Mn |
| Jun 30, 2024 | 4.65 Mn |
| Mar 31, 2024 | 4.71 Mn |
| Dec 31, 2023 | 794.09 Mn |